Charles River Laboratories And Wheeler Bio Announce Agreement To Build And Operate RightSourceSM Laboratory
Portfolio Pulse from Happy Mohamed
Charles River Laboratories (NYSE:CRL) and Wheeler Bio have announced an agreement to implement RightSource, an insourced biologics testing lab, at Wheeler Bio's CGMP biologics manufacturing facility in Oklahoma City. The lab will be operated by Charles River employees and will support QC testing needs for Wheeler and its third-party clients.
May 31, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Charles River Laboratories partners with Wheeler Bio to implement RightSource biologics testing lab, expanding its services and potentially increasing revenue.
The partnership with Wheeler Bio allows Charles River Laboratories to expand its RightSource biologics testing lab services to more clients. This could lead to increased demand for their services, resulting in potential revenue growth. The news is highly relevant to CRL as it directly involves their business expansion and has a high importance for investors due to the potential impact on revenue.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100